Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
NCT Number: NCT02020148
The goal of this research study is to understand the relationship between the hormone oxytocin and postpartum mood.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Chicago, Illinois, 60611, United States
Postpartum depression (PPD) affects some one in five new mothers, and adversely influences maternal adaptation to motherhood. While it is known that women with a prior history of depression, or depression during pregnancy, are at elevated risk for postpartum depression, many women with no prior history of depression or other risk factors go on to develop depression in the postpartum period. Considering the grave consequences of postpartum depression on maternal infant bonding and childhood psychological development, it is critical to develop reliable methods to identify which women, who are not depressed during pregnancy, will become depressed after delivery.
The biological pathways leading to depression at any time in life, including around pregnancy, are still poorly characterized. Oxytocin (OT), a hormone involved in delivery and lactation, has received recent attention regarding its additional role in maternal emotions and care taking behaviors after birth. The primary goal is explore the relationship between plasma oxytocin and postpartum mood.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4-6 weeks post delivery
The IDS-SR-30 is a validated, widely used tool to evaluate depressive symptoms and clinical depression. Participants will complete this questionnaire in person or through telephone interview.
Northwestern University
Other
Can Prenatal Plasma Oxytocin Concentration Predict Likelihood of Postpartum Depression? An Opportunity for Early Intervention and Prevention in a Vulnerable Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05322161
Anxiety, Anxiety Disorders
Seattle, Washington, United States
View Trial DetailsNCT04925765
Anxiety Disorders, Anxiety and Depression
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT03880032
Anxiety, Anxiety Disorders
Rawalpindi, Pakistan
View Trial DetailsNCT03415321
Anxiety Disorders, Behavior
Konya, Turkey (Türkiye)
View Trial Details